Sunday 21 May
15:30-16:45
Elevated triglycerides and reduction of CV risk: What did we learn after REDUCE-IT?
FIBRATES: The PROMINENT trial
Kausik Ray, UK
Kausik Ray, UK
TG vs apo B reduction
Brian Ference, UK
Brian Ference, UK
Recent trials with Omega 3 lessons to be learned
Alberto Zambon, Italy
Alberto Zambon, Italy
EPA: Mechanism(s) of action
Chris Packard, France
Chris Packard, France
12:30-13:45
The continuum of cardiometabolic risk-from NASH, Obesity and Diabetes
NASH- What is it and how does it increase risk of Atherosclerosis
Stefano Romeo, Sweden
Stefano Romeo, Sweden
Attenuating lifetime risk of Diabetes through personalised weight management
Brian Ference, UK
Brian Ference, UK
The role of GLP-1 in preventing ASCVD in DM and Obesity
Lale Tokgözoğlu, Turkey
Lale Tokgözoğlu, Turkey
EAS have independently organised all matters related to this programme, including content and presenters. We acknowledge financial support, in the form of an educational grant, received from industry in support of the programme.
